Insights
Israeli Cannabis Breakthrough Opens New Hope for Fatty Liver Disease
NEW YORK- A new study out of Israel has put Cannabis back into one of the most important conversations in modern medicine: metabolic disease. Researchers at the Hebrew University of Jerusalem have reported that two non-intoxicating Cannabis compounds, CBD and CBG, significantly reduced liver fat and improved metabolic health in experimental models of fatty liver ...
Why the Endocannabinoid System Is the Future of Cannabis Medicine
NEW YORK- Cannabis medicine is entering a more serious phase. For years, the conversation has focused on pain, sleep, anxiety, appetite, and symptom relief. Those remain important, but they may only be the beginning. The deeper opportunity is understanding how Cannabis interacts with one of the body’s most important regulatory networks: the endocannabinoid system. The ...
Cannabis, Inflammation, and the Next Frontier in Root-Cause Medicine
NEW YORK- Cannabis medicine is moving beyond pain, sleep, and anxiety. One of the most important next frontiers may be inflammation, because the endocannabinoid system plays a direct role in how the body regulates immune response, inflammatory signaling, pain, metabolism, and recovery. That matters because chronic inflammation is not just a symptom of disease. It ...
Why Metabolic Dysfunction May Be the Next Frontier for Cannabinoid Medicine
NEW YORK- Metabolism is the system that determines how the body produces, distributes, and uses energy, and it sits at the center of modern chronic disease. While it is often reduced to a discussion of calories or weight, metabolism is fundamentally a cellular process governed by hormonal signaling, mitochondrial function, and nutrient utilization. When it ...
LeafLink Releases 2026 Wholesale Cannabis Pricing Guide
NEW YORK – LeafLink, a unified B2B marketplace and technology platform built specifically for the Cannabis industry, published its annual 2026 Wholesale Cannabis Pricing Guide, delivering one of the most comprehensive data snapshots the legal Cannabis trade has produced to date. The report draws on billions of dollars in actual transactions and covers more than ...
Allied Market Research: Global Cannabis Market to Generate $149B by 2031
PORTLAND – A report recently published by Allied Market Research projects the global Cannabis market will reach $148.9 billion by 2031, up from $25.7 billion in 2021 – a nearly sixfold increase over a decade, compounding at 20.1% annually. For the industry that spent most of the 20th century in legal exile, those figures represent ...
Rescheduling: What it Actually Means for US Cannabis
LOS ANGELES – For years, the Cannabis industry's most reliable tradition has been misreading federal signals. When the DEA floated rescheduling proposals, operators popped champagne. When states passed adult-use laws, investors rushed in ahead of federal clarity. And last week, when Acting Attorney General Todd Blanche signed a final order reclassifying state-licensed medical Cannabis to ...
Cannabis 3.0 — The Body Was Designed to Heal
LOS ANGELES- The cannabis industry is entering a new phase. The first era—Cannabis 1.0—was defined by prohibition and the fight for legalization. Cannabis 2.0 followed, driven by commercialization: brands, retail expansion, and the rapid scaling of products into consumer markets. What comes next is fundamentally different. Cannabis 3.0 is not about access or scale. It ...
Industrial Hemp Market to Exceed $7B by 2031, Driven by Construction and Wellness
LOS ANGELES – The global industrial hemp market is on track to nearly double in value over the next five years, according to the latest report by Mordor Intelligence that projects the market to grow from $3.57 billion in 2026 to $7.95 billion by 2031, reflecting a CAGR of 17.36%. That trajectory places industrial hemp ...
Oklahoma Law Review Claims 280E No Longer Applies Post-Cannabis Rescheduling
TULSA – A forthcoming article in the Oklahoma Law Review contends that federal rescheduling of Cannabis to Schedule III would place the plant outside the reach of Internal Revenue Code Section 280E, potentially ending the government’s ability to apply the provision to Cannabis businesses, including collection efforts tied to prior years. The analysis, written by ...
ATACH Publishes Report on Updated Hemp Regulations
WASHINGTON – Federal lawmakers moved last year to shut down a major loophole in hemp rules, and the American Trade Association for Cannabis and Hemp (ATACH) has now delivered a clear-eyed examination outlining the regulatory shifts now facing hemp-derived products and what those changes mean for producers, processors, and retailers nationwide. The 2026 Hemp Intoxicants ...
Trump Fast Tracks Psychedelic Research
WASHINGTON D.C- President Donald Trump has signed a sweeping executive order to accelerate psychedelic research and expand patient access across the United States—marking one of the most significant federal policy shifts the sector has seen to date. First reported by Psychedelic Alpha, the order directs federal agencies to reduce regulatory barriers, deploy funding, and compress ...
Five Years After Legalization, Virginia Still Isn’t Ready—But It’s Getting Closer
Virginia’s Cannabis market has been “legal” on paper for years. In practice, it’s been stuck in neutral—possession allowed, but no regulated retail system to match it. That may finally be shifting. The latest move out of Richmond Abigail Spanberger is stepping in with a set of proposed amendments that reshape how—and when—Virginia’s long-delayed Cannabis sales ...
Pre-Rolls Outpace Flower as Top U.S. Cannabis Category by Unit Sales
LOS ANGELES – Pre-rolled Cannabis products became the leading category in the United States by the number of units sold in 2025, according to data released in the State of the Pre-Roll Market 2026 report from Custom Cones USA. The category generated $3.6 billion in revenue and moved 383.2 million units last year, capturing 15.9% ...
German Pharmacies Offer Cannabis Cheaper Than Darknet
BERLIN – Cannabis flower available by prescription through German pharmacies has for the first time undercut prices on the darknet, according to data released by EKOCAN as part of the official evaluation of the country’s partial Сannabis legalization. The shift, documented in the second interim report of the EKOCAN evaluation project, marks a milestone in ...
Two in Three Americans Support Legal Home Cannabis Cultivation, The Harris Poll Finds
LOS ANGELES – A new national survey shows that a clear majority of U.S. adults support the right to grow Cannabis at home, even as many Cannabis users express concerns about pesticides in store-bought products. The poll, conducted on behalf of Royal Queen Seeds (RQS) found that 61% of Americans aged 21-plus favor legalizing personal ...
Whitney Economics Updates Review of Federal Tax Pressure on Legal Cannabis Operators
PORTLAND – Whitney Economics refreshed its analysis on the federal tax burden facing state-regulated legal Cannabis operators, estimating that they paid $2.24 billion in excess taxes in 2025 alone due to Section 280E of the Internal Revenue Code. “The amount of additional taxes Cannabis operators pay is staggering. In 2025, there was an estimated ...
A LIFE IN A DAY: Clayton Smith: CEO: AULV Health
NEW YORK- A LIFE IN A DAY offers viewers another look at well-known people who are in various areas of the industry. We can see from their LinkedIn profile what they do for work, but what do they think about during the day? What occupies their time? What do they feel? This is about their ...
Distressed Assets Are Reshaping Cannabis M&A
LOS ANGELES- Distressed assets are now driving the next phase of Cannabis M&A. What appears on the surface to be a slowdown in deal activity is, in reality, a shift in how transactions are being structured and executed. The industry is moving away from expansion-driven acquisitions toward a more disciplined, opportunity-driven model built around distressed ...
Why NECANN Boston Is Becoming a Strategic Growth Engine for Cannabis Brands
BOSTON- If you want to understand where the U.S. Cannabis industry is heading next, look east—and more specifically, look at NECANN Boston. Returning April 24–25 at the Hynes Convention Center, the New England Cannabis Convention has grown into far more than a regional trade show. It is now one of the most effective platforms for ...
Global Cannabis Packaging Market Size to Reach $12.8B by 2035, FMI Forecasts
LOS ANGELES – As legalization advances worldwide, Cannabis packaging has become a strategic priority. From rigid, child-resistant designs leading in North America to compliant, sustainable solutions gaining traction in Europe, Asia, and Latin America, this supporting sector reflects the industry's push for regulation, branding, and consumer trust. Future Market Insights (FMI) projects the global Cannabis ...
High Tide Subsidiary Targets Supplier Role in Medicare CBD Pilot
CALGARY – High Tide Inc. has announced that its U.S.-based CBD subsidiary, NuLeaf Naturals, started negotiations with healthcare institutions to supply products for a new federal pilot program that lets certain Medicare beneficiaries receive up to $500 worth of eligible hemp-derived CBD products per year free of charge. The pilot, formally known as the Substance ...
NECANN Returns to Boston as East Coast Cannabis Expansion Accelerates
NEW YORK- The East Coast Cannabis market continues to mature—and NECANN is positioning itself right at the center of that growth. On April 24–25, the 12th Annual New England Cannabis Convention returns to the Hynes Convention Center in Boston, bringing together more than 300 exhibitors and over 50 speaker sessions across six programming tracks. Presented ...
Latino Cannabis Alliance Forms to Unite Nationwide
JERSEY CITY, NJ — The Latino Cannabis Alliance (LCA) today announced its official launch as a national coalition of U.S.-based Latino cannabis advocacy leaders to meet the growing need for organized Latino representation in the cannabis ecosystem. The LCA is dedicated to growing Latino political influence in the United States, building bridges across diverse Latino ...
Vlasic Labs CBD Products Qualify for CMS Medicare Pilot Program
BLOOMFIELD HILLS – Vlasic Labs announced that its cannabidiol product line meets the qualification standards for a new federal pilot program run by the Centers for Medicare and Medicaid Services. The Michigan company’s hemp-derived offerings now satisfy the requirements of the Substance Access Beneficiary Engagement Incentive, a limited initiative that lets certain participating healthcare organizations ...
